Here's Why Eli Lilly Broke to the Upside
Let's review the charts and indicators.
2 Small-Caps Still Worth Considering in This Red-Hot Market
Oncology concern Exelixis and biopharma Ardelyx offer reasons to believe their shares should rise in the months ahead.
How to Play Emergent BioSolutions Right Now
A correction in EBS could soon set up an attractive opportunity.
The Week That Was, Q4 Earnings Expectations, Key Investor and Healthcare Events
This Friday several banks begin the unofficial kickoff of 'earnings season'.
This Dividend Aristocrat Would Be a Noble Addition to Your Portfolio
The company's size and scale are nearly unmatched in its sector.
Here's My Biotech Pick for 2021
But know first that to really succeed in the sector, diversifying is key.
CVS Health's Charts Are Close to an Important Breakout
Aggressive traders could go long CVS at current levels.
AbbVie Is a Stock to Position for 2021
Let's review the charts and indicators.
McKesson's Charts Still Look Bullish
Let's review the charts and indicators.
The Correction in AstraZeneca Could Be Nearing an End
Aggressive traders might want to look past any near-term price weakness and consider a small long position.